Works matching Genentech Inc.
Results: 4127
Estimating Hypothetically Negotiated Royalty Rates after Medlmmune, Inc. v. Genentech, Inc., et al.
- Published in:
- Journal of Legal Economics, 2008, v. 14, n. 3, p. 43
- By:
- Publication type:
- Article
DETHRONING LEAR? INCENTIVES TO INNOVATE AFTER MEDIMMUNE.
- Published in:
- Berkeley Technology Law Journal, 2009, v. 24, n. 2, p. 971
- By:
- Publication type:
- Article
Cabilly patent finale.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 8, p. 846, doi. 10.1038/nbt0808-846b
- By:
- Publication type:
- Article
Recent Supreme Court decisions and licensing power.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 2, p. 183, doi. 10.1038/nbt0208-183
- By:
- Publication type:
- Article
DECLARATORY RELIEF AFTER MEDIMMUNE.
- Published in:
- Lewis & Clark Law Review, 2010, v. 14, n. 2, p. 491
- By:
- Publication type:
- Article
AN EXTRAORDINARY DECADE: THE SUPREME COURT TAKES CHARGE OF RESHAPING PATENT LAW.
- Published in:
- Charleston Law Review, 2010, v. 4, n. 4, p. 887
- By:
- Publication type:
- Article
BURDEN OF PROOF IN MEDTRONIC: THE FEDERAL CIRCUIT'S IDIOSYNCRATIC PATENT JURISPRUDENCE VETOED, AGAIN.
- Published in:
- Berkeley Technology Law Journal, 2015, v. 30, p. 777
- By:
- Publication type:
- Article
The Federal Circuit's Interpretation and Application of the MedImmune Standard for Declaratory Judgment Jurisdiction.
- Published in:
- Texas Intellectual Property Law Journal, 2011, v. 19, n. 3, p. 331
- By:
- Publication type:
- Article
THE RETURN OF THE KING: RETHINKING LEAR, MEDIMMUNE, AND THE EFFECTS OF LICENSEE ESTOPPEL IN THE CONTEXT OF AIA POST-GRANT PROCEDURES.
- Published in:
- New York University Annual Survey of American Law, 2015, v. 71, n. 1, p. 81
- By:
- Publication type:
- Article
U.S. Supreme Court Makes It Easier for Patent Licensee to Have Its Cake and Eat It Too.
- Published in:
- JOM: The Journal of The Minerals, Metals & Materials Society (TMS), 2007, v. 59, n. 4, p. 80, doi. 10.1007/s11837-007-0057-9
- By:
- Publication type:
- Article
Supreme Court Says You Can License and Sue.
- Published in:
- Research Technology Management, 2007, v. 50, n. 2, p. 9
- By:
- Publication type:
- Article
Supreme Court sides with MedImmune.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 104, doi. 10.1038/nrd2249
- By:
- Publication type:
- Article
US allows patent dilution.
- Published in:
- Chemistry & Industry, 2007, n. 2, p. 9
- By:
- Publication type:
- Article
Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphomaThe development of the model and the subsequent analyses were supported by a grant from Genentech, Inc. The sponsors of the study had no role in the model design, cost-utility analysis, or interpretation of the results. All investigators had unlimited access to the model and data. No limitations on publication were imposed. The authors made the final decisions on all analyses presented in the article.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 8, p. 1644
- By:
- Publication type:
- Article
Medimmune v. Genentech: A Game-Theoretic Analysis of the Supreme Court's Continued Assault on the Patentee.
- Published in:
- Marquette Intellectual Property Law Review, 2011, v. 15, n. 2, p. 503
- By:
- Publication type:
- Article
EXPANDING STANDING IN PATENT DECLARATORY JUDGMENT ACTIONS TO BETTER AIR PUBLIC POLICY CONSIDERATIONS.
- Published in:
- New York University Law Review, 2013, v. 88, n. 1, p. 476
- By:
- Publication type:
- Article
How Much Is More Life Worth?
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Great company, bad stock.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 2, p. 173, doi. 10.1038/nbt0205-173
- By:
- Publication type:
- Article
Genentech relaunched with independence intact.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 7, p. 634, doi. 10.1038/10842
- By:
- Publication type:
- Article
Intravitreal Ranibizumab Tedavisi Uygulanan Retina Ven Dal Tıkanıklığına Bağlı Maküla Ödemi Olgularında Görme Keskinliğine Etki Eden Prognostik Faktörler.
- Published in:
- Retina-Vitreus/Journal of Retina-Vitreous, 2014, v. 22, n. 2, p. 103
- By:
- Publication type:
- Article
Oncogenic BRAF: A new potential therapeutic target.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 112
- Publication type:
- Article
Announcements.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 9, p. 743
- Publication type:
- Article
First-Line Maintenance With Erlotinib/Bevacizumab Improves Progression-Free Survival in Advanced Lung Cancer.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 2, p. 182
- Publication type:
- Article
Announcements.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1877
- Publication type:
- Article
Trastuzumab and Beyond: New Possibilities for the Treatment of HER2-Positive Breast Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1763
- By:
- Publication type:
- Article
Fourth Phase III Study Shows Trastuzumab/Chemotherapy Improved Disease-Free Survival in Breast Cancer Patients.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 11, p. 1
- Publication type:
- Article
Imaging: Cancer caught in the act.
- Published in:
- Nature, 2014, v. 509, n. 7499, p. 148, doi. 10.1038/509148a
- By:
- Publication type:
- Article
Bevacizumab for neovascular age-related macular degeneration (ABC trial): multicenter randomized double-masked study.
- Published in:
- Expert Review of Clinical Pharmacology, 2010, v. 3, n. 6, p. 747, doi. 10.1586/ecp.10.58
- By:
- Publication type:
- Article
Genentech Access Solutions.
- Published in:
- 2018
- Publication type:
- Product Review
LIMITING UNFETTERED CHALLENGES TO PATENT VALIDITY: UPHOLDING NO-CHALLENGE CLAUSES IN PRE-LITIGATION PATENT SETTLEMENTS BETWEEN PREEXISTING PARTIES TO A LICENSE.
- Published in:
- Cardozo Law Review, 2014, v. 35, n. 4, p. 1649
- By:
- Publication type:
- Article
CITY OF HOPE V. GENENTECH: KEEPING FIDUCIARY DUTIES WHERE THEY BELONG.
- Published in:
- Berkeley Technology Law Journal, 2009, v. 24, n. 1, p. 179
- By:
- Publication type:
- Article
DECLARATORY JUDGMENT ACTIONS IN PATENT CASES: THE FEDERAL CIRCUIT'S RESPONSE TO MEDIMMUNE V. GENENTECH.
- Published in:
- Berkeley Technology Law Journal, 2008, v. 23, n. 1, p. 161
- By:
- Publication type:
- Article
FDA actions.
- Published in:
- OB/GYN Clinical Alert, 2010, p. 2
- Publication type:
- Article
MRD‐NEGATIVITY AFTER FRONTLINE DLBCL THERAPY: POOLED ANALYSIS OF 6 CLINICAL TRIALS.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 177, doi. 10.1002/hon.3163_112
- By:
- Publication type:
- Article
US jury split over hormone patent case...
- Published in:
- Nature, 1999, v. 399, n. 6736, p. 512, doi. 10.1038/21023
- By:
- Publication type:
- Article
Charges fly in $1bn hormone patent battle.
- Published in:
- Nature, 1999, v. 399, n. 6734, p. 289, doi. 10.1038/20492
- By:
- Publication type:
- Article
A sorry affair.
- Published in:
- Nature, 1999, v. 399, n. 6734, p. 285, doi. 10.1038/20480
- Publication type:
- Article
Drug & therapeutics update.
- Published in:
- 2013
- Publication type:
- Product Review
MARKETPLACE: Drug & therapeutics update.
- Published in:
- Oncology Exchange, 2012, v. 11, n. 3, p. 47
- Publication type:
- Article
Phase III/IV.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 7, p. 14
- Publication type:
- Article
PHARMACY CORNER.
- Published in:
- Oncology Nursing Forum, 2000, v. 27, n. 1, p. 107
- By:
- Publication type:
- Article
Drugs in traffic: the road to approval.
- Published in:
- Nature Medicine, 2011, v. 17, n. 12, p. 1542, doi. 10.1038/nm1211-1542
- Publication type:
- Article
Difficult decisions.
- Published in:
- 2011
- Publication type:
- Editorial
Companies race to develop first Hedgehog inhibitor cancer drug.
- Published in:
- Nature Medicine, 2011, v. 17, n. 5, p. 523, doi. 10.1038/nm0511-523
- By:
- Publication type:
- Article
Fearful of Avastin's fate, Genentech asks for unusual hearing.
- Published in:
- Nature Medicine, 2011, v. 17, n. 3, p. 233, doi. 10.1038/nm0311-233
- By:
- Publication type:
- Article
Omalizumab for the treatment of chronic urticaria.
- Published in:
- Expert Review of Clinical Immunology, 2015, v. 11, n. 2, p. 171, doi. 10.1586/1744666X.2015.993971
- By:
- Publication type:
- Article
Drug combination in rheumatoid arthritis treatment.
- Published in:
- Expert Review of Clinical Immunology, 2007, v. 3, n. 1, p. 1
- Publication type:
- Article
THE WEATHERVANE.
- Published in:
- Hawaii Medical Journal, 2006, v. 65, n. 9, p. 274
- By:
- Publication type:
- Article
Roche bids for remaining Genentech stake.
- Published in:
- Nature, 2008, v. 454, n. 7203, p. 381, doi. 10.1038/454381a
- Publication type:
- Article
Treat and extend regimen with aflibercept for chronic central retinal vein occlusions: 2 year results of the NEWTON study.
- Published in:
- International Journal of Retina & Vitreous, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40942-019-0159-x
- By:
- Publication type:
- Article